A retrospective, real world study of use of nivolumab and pembrolizumab in patients with metastatic head and neck squamous cell carcinoma
Latest Information Update: 17 Jul 2021
At a glance
- Drugs Nivolumab (Primary) ; Pembrolizumab (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 17 Jul 2021 New trial record